Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN10494545451B reveals high-yield glycosylation route. Eliminates heavy metals for cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN113024615A discloses efficient chiral ligands enabling cheap metal catalysis for API synthesis, offering significant cost reduction and supply chain stability.
Explore the novel synthesis of chiral oxazoline-zinc complexes via patent CN102212078A, offering robust catalytic solutions and supply chain stability for pharmaceutical manufacturing.
Patent CN110698507A details a ligand-free Pd-catalyzed C-H alkenylation method for aryl vinyl silanes, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Ru-catalyzed C-H activation method for benzofuran acids. Green oxidant, scalable process for API intermediates and natural products like diptoindonesin G.
Novel synthesis route offers high yield and safety for finafloxacin intermediate production. Reduces toxic waste and ensures supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Discover the patented protic solvent method for producing high-purity ketimines. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN111253254A details a green CuCl2-catalyzed dichlorination method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN1219758C reveals a scalable inclusion resolution method for di-tert-butyl thiosulfinate, offering dual-configuration access and significant cost reduction potential.
Patent CN111303089B details a mild Mn-mediated trifluoromethylation. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable room temperature processes.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Novel metal-free method using DMSO for high-yield ketone synthesis. Offers cost-effective scalable solutions for global pharmaceutical supply chains.
Discover novel pyrroline chiral bisphosphine ligands from patent CN110041365B. High enantioselectivity synthesis for reliable pharmaceutical intermediate supply chains.
Discover the efficient 5-step synthesis of (-)-newbouldine via FeCl3 catalysis. A reliable supplier solution for high-purity pharmaceutical intermediates with reduced toxicity.
Patent CN101973954A reveals a green, aqueous synthesis route for 3,4-dihydro-1,3-oxazin-2-ones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110981823B reveals high-purity triazole synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.
Patent CN108659043B details a cost-effective CAN-catalyzed route for E-alkenyl diphenylphosphines, offering superior atom economy and simplified purification for pharmaceutical intermediates.